NFKB1 and neoplasm: Cancer cells exploit ROS by dynamically balancing their production, activating oncogenic pathways (e.g., MAPK/NF-κB), and suppressing antioxidants, collectively enhancing tumor progression (Aggarwal et al., 2019).